Background Malignant pleural effusion (MPE) is a common problem for people with cancer
as a result of malignant infiltration of the pleura. It is usually associated with considerable …

Background Approximately half of all patients with metastatic cancer develop a malignant
pleural effusion which is likely to lead to a significant reduction in quality of life secondary to …

INTRODUCTION The discovery of malignant cells in pleural fluid and/or parietal pleura
signifies disseminated or advanced disease and a reduced life expectancy in patients with …

2 PATHOPHYSIOLOGY The pleura consists of five main anatomical compartments (fig 2):
the parietal systemic circulation (branches of the intercostal and internal mammary arteries) …

Purpose: To provide information about available agents for chemical pleurodesis. Data
Sources: A MEDLINE search (1966 to October 1992) was conducted using the terms …

The aim of this study was to review systematically the available evidence on pleurodesis for
malignant effusion, focusing on the choice of the agents, route of delivery and other …

Study objective To evaluate the efficacy of small-bore (12 French van Sonnenberg)
catheters compared with standard large-borechest tubes in the drainage and sclerotherapy …

Objective To assess the efficacy, permanence, and safety of thoracoscopic talc poudrage
(TTP) for pleurodesis in malignant effusions. Design Retrospective. Participants Patients …

Background Malignant pleural effusion (MPE) is a common problem for people with cancer
and usually associated with considerable breathlessness. A number of treatment options are …

Objective Symptomatic malignant pleural effusions are common sequelae in patients with
certain malignancies. Pleurodesis via bedside thoracostomy is the current treatment option …